Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Wei Jiang, Mingze Tang, Limin Yang, Xu Zhao, Jun Gao, Yue Jiao, Tao Li, Cai Tie, Tianle Gao, Yanxing Han, Jian-Dong Jiang
Author Information
  1. Wei Jiang: Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Shaoxing, China.
  2. Mingze Tang: State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China.
  3. Limin Yang: Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Shaoxing, China.
  4. Xu Zhao: First Clinical Division, Peking University Hospital of Stomatology, Beijing, China.
  5. Jun Gao: Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences & Peking Union Medical College, Beijing, China.
  6. Yue Jiao: Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
  7. Tao Li: Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
  8. Cai Tie: State Key Laboratory of Coal Resources and Safety Mining, China University of Mining and Technology, Beijing, China.
  9. Tianle Gao: State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China.
  10. Yanxing Han: State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China.
  11. Jian-Dong Jiang: State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China.

Abstract

Chronic pain is one of the most prevalent health problems. The establishment of chronic pain is complex. Current medication for chronic pain mainly dependent on anticonvulsants, tricyclic antidepressants and opioidergic drugs. However, they have limited therapeutic efficacy, and some even with severe side effects. We turned our interest into alkaloids separated from traditional Chinese medicine (TCM), that usually act on multiple drug targets. In this article, we introduced the best-studied analgesic alkaloids derived from TCM, including tetrahydropalmatine, aloperine, oxysophocarpine, matrine, sinomenine, ligustrazine, evodiamine, brucine, tetrandrine, Stopholidine, and lappaconitine, focusing on their mechanisms and potential clinical applications. To better describe the mechanism of these alkaloids, we adopted the concept of drug-cloud (dCloud) theory. dCloud illustrated the full therapeutic spectrum of multitarget analgesics with two dimensions, which are "direct efficacy", including inhibition of ion channels, activating γ-Aminobutyric Acid/opioid receptors, to suppress pain signal directly; and "background efficacy", including reducing neuronal inflammation/oxidative stress, inhibition of glial cell activation, restoring the balance between excitatory and inhibitory neurotransmission, to cure the root causes of chronic pain. Empirical evidence showed drug combination is beneficial to 30-50% chronic pain patients. To promote the discovery of effective analgesic combinations, we introduced an ancient Chinese therapeutic regimen that combines herbal drugs with "Jun", "Chen", "Zuo", and "Shi" properties. In dCloud, "Jun" drug acts directly on the major symptom of the disease; "Chen" drug generates major background effects; "Zuo" drug has salutary and supportive functions; and "Shi" drug facilitates drug delivery to the targeted tissue. Subsequently, using this concept, we interpreted the therapeutic effect of established analgesic compositions containing TCM derived analgesic alkaloids, which may contribute to the establishment of an alternative drug discovery model.

Keywords

References

  1. Pain. 2008 Aug 31;138(2):255-266 [PMID: 18258368]
  2. Zhongguo Yao Li Xue Bao. 1996 May;17(3):259-61 [PMID: 9812752]
  3. PLoS One. 2016 Sep 13;11(9):e0162875 [PMID: 27622550]
  4. Cardiovasc Drug Rev. 2005 Summer;23(2):161-72 [PMID: 16007232]
  5. Am J Transl Res. 2017 May 15;9(5):2266-2275 [PMID: 28559977]
  6. Vaccine. 2009 Aug 6;27(36):4883-90 [PMID: 19559122]
  7. Pharm Biol. 2012 Aug;50(8):1053-61 [PMID: 22775422]
  8. Curr Biol. 2005 Mar 8;15(5):R154-8 [PMID: 15753022]
  9. Neuroscience. 2017 Sep 1;358:28-36 [PMID: 28663089]
  10. Pharmacol Biochem Behav. 2005 Mar;80(3):419-25 [PMID: 15740784]
  11. Pain Res Manag. 2020 May 6;2020:1876862 [PMID: 32454918]
  12. Neuron. 2016 Jan 6;89(1):11-36 [PMID: 26748087]
  13. Sci Rep. 2014 Jan 28;4:3905 [PMID: 24469566]
  14. Front Physiol. 2021 Feb 09;11:523769 [PMID: 33633575]
  15. Life Sci. 2006 Jul 10;79(7):665-73 [PMID: 16566946]
  16. Pharm Biol. 2014 Aug;52(8):1052-9 [PMID: 24601951]
  17. Hum Cell. 2019 Jul;32(3):251-259 [PMID: 30701373]
  18. Brain Res Bull. 2016 Jul;125:30-43 [PMID: 27060612]
  19. J Neuroinflammation. 2007 Sep 19;4:23 [PMID: 17880684]
  20. Drugs Today (Barc). 2008 May;44(5):353-68 [PMID: 18548137]
  21. Biomed Pharmacother. 2018 Sep;105:1254-1268 [PMID: 30021362]
  22. Biomol Ther (Seoul). 2018 Sep 1;26(5):432-438 [PMID: 29310424]
  23. Planta Med. 2015 Jul;81(10):791-7 [PMID: 26132856]
  24. Nat Rev Neurosci. 2018 Mar;19(3):138-152 [PMID: 29416128]
  25. J Pharm Pharmacol. 2015 Jan;67(1):1-19 [PMID: 25244533]
  26. Am J Transl Res. 2017 Sep 15;9(9):4083-4093 [PMID: 28979683]
  27. Am J Chin Med. 2018;46(1):1-23 [PMID: 29298518]
  28. Prog Neurobiol. 1998 Oct;56(2):211-35 [PMID: 9760702]
  29. Eur J Pharmacol. 1997 Oct 22;337(2-3):223-6 [PMID: 9430418]
  30. Med Sci Monit. 2018 Apr 05;24:2018-2024 [PMID: 29620048]
  31. J Alzheimers Dis. 2018;63(3):965-975 [PMID: 29710703]
  32. Pharmazie. 2016 Jul 7;71(7):408-412 [PMID: 29441918]
  33. Int J Biochem Cell Biol. 2004 Oct;36(10):1861-7 [PMID: 15203098]
  34. CNS Spectr. 2019 Oct;24(5):461-466 [PMID: 31566163]
  35. Int J Mol Sci. 2018 Jul 24;19(8): [PMID: 30042373]
  36. Neurochem Res. 2010 Sep;35(9):1368-75 [PMID: 20521101]
  37. J Ethnopharmacol. 2015 Aug 22;172:10-29 [PMID: 26087234]
  38. Curr Opin Rheumatol. 2020 Jan;32(1):57-63 [PMID: 31644463]
  39. J Ethnopharmacol. 2020 Dec 5;263:113231 [PMID: 32758577]
  40. CNS Drugs. 2019 Oct;33(10):943-955 [PMID: 31578704]
  41. Front Pharmacol. 2020 Apr 03;11:377 [PMID: 32308621]
  42. Eur J Pharmacol. 2020 Oct 5;884:173397 [PMID: 32717192]
  43. Life Sci. 1986 Aug 4;39(5):415-22 [PMID: 2874465]
  44. Eur J Pharmacol. 2021 Mar 15;895:173869 [PMID: 33454375]
  45. Int Rev Neurobiol. 2017;135:279-295 [PMID: 28807162]
  46. Zhongguo Yao Li Xue Bao. 1986 Jul;7(4):311-4 [PMID: 2954388]
  47. J Toxicol Environ Health. 1995 Oct;46(2):233-48 [PMID: 7563220]
  48. Anesthesiology. 2018 Aug;129(2):343-366 [PMID: 29462012]
  49. Biol Pharm Bull. 2005 May;28(5):845-8 [PMID: 15863891]
  50. Am J Med. 2020 Jun;133(6):675-678 [PMID: 32145207]
  51. Pharmacol Res. 2019 Dec;150:104520 [PMID: 31706012]
  52. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):775-9 [PMID: 12921909]
  53. Cell Mol Neurobiol. 2008 Dec;28(8):1049-56 [PMID: 18379870]
  54. J Inflamm (Lond). 2017 Jun 8;14:13 [PMID: 28603455]
  55. Int Immunopharmacol. 2020 Oct;87:106805 [PMID: 32731179]
  56. J Neuroinflammation. 2017 Aug 31;14(1):174 [PMID: 28859670]
  57. Front Pharmacol. 2020 Sep 16;11:01067 [PMID: 33041782]
  58. Zhongguo Zhong Yao Za Zhi. 2004 Apr;29(4):371-3 [PMID: 15706881]
  59. Med Sci Monit. 2006 Jul;12(7):RA130-47 [PMID: 16810145]
  60. Cell Mol Neurobiol. 2008 Jun;28(4):491-9 [PMID: 17710533]
  61. Int J Mol Sci. 2013 Dec 05;14(12):23751-61 [PMID: 24317434]
  62. Pain. 2015 Apr;156(4):569-576 [PMID: 25785523]
  63. J Med Food. 2010 Oct;13(5):1125-32 [PMID: 20828314]
  64. Pain. 2019 Jan;160(1):19-27 [PMID: 30586067]
  65. Neuroimage. 2020 Apr 15;210:116532 [PMID: 31958584]
  66. J Pharm Pharmacol. 2020 Nov;72(11):1491-1512 [PMID: 32696989]
  67. Biochem Biophys Res Commun. 2014 Sep 5;451(4):568-73 [PMID: 25128276]
  68. Biochem Biophys Res Commun. 2016 Sep 2;477(4):881-886 [PMID: 27378427]
  69. Curr Rheumatol Rev. 2015;11(2):70-85 [PMID: 26138918]
  70. Med Clin North Am. 2016 Jan;100(1):55-64 [PMID: 26614719]
  71. J Clin Psychiatry. 2008;69 Suppl E1:4-7 [PMID: 18494537]
  72. Br J Pharmacol. 2016 May;173(10):1693-702 [PMID: 26915970]
  73. MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427 [PMID: 30605448]
  74. Int Arch Allergy Appl Immunol. 1988;85(4):404-9 [PMID: 3356473]
  75. Int J Mol Sci. 2017 Nov 21;18(11): [PMID: 29160850]
  76. Acta Med Okayama. 1976 Feb;30(1):1-20 [PMID: 61710]
  77. Anaesth Intensive Care. 1998 Apr;26(2):137-46 [PMID: 9564390]
  78. Phytochem Rev. 2020;19(2):449-489 [PMID: 32336965]
  79. Small. 2020 Jan;16(2):e1905233 [PMID: 31814271]
  80. Adv Pharmacol. 2016;75:325-61 [PMID: 26920018]
  81. Eur J Pharmacol. 2019 Jul 5;854:101-108 [PMID: 30954565]
  82. Autoimmunity. 2007 Nov;40(7):532-9 [PMID: 17966044]
  83. Mov Disord. 2009;24 Suppl 2:S656-64 [PMID: 19877243]
  84. Ann Transl Med. 2020 Nov;8(22):1525 [PMID: 33313270]
  85. BMC Complement Altern Med. 2015 Feb 27;15:36 [PMID: 25888429]
  86. Nat Rev Rheumatol. 2012 Nov;8(11):656-64 [PMID: 23007741]
  87. J Ethnopharmacol. 2020 Feb 10;248:112172 [PMID: 31442619]
  88. Front Pharmacol. 2020 May 07;11:588 [PMID: 32477114]
  89. Neurochem Int. 2011 Apr;58(5):564-73 [PMID: 21272608]
  90. Pain Physician. 2020 Mar;23(2):175-201 [PMID: 32214301]
  91. Curr Med Chem. 2007;14(28):2996-3002 [PMID: 18220736]
  92. Metab Brain Dis. 2017 Feb;32(1):211-219 [PMID: 27585465]
  93. Sheng Li Xue Bao. 2007 Jun 25;59(3):285-92 [PMID: 17579782]
  94. Neurosci Lett. 2014 Jan 24;559:67-71 [PMID: 24269875]
  95. Cell Mol Neurobiol. 2021 Jan;41(1):115-127 [PMID: 32279133]
  96. Scand J Pain. 2017 Dec 29;5(4):249-255 [PMID: 29913715]
  97. Neurosci Lett. 2016 Feb 26;615:78-82 [PMID: 26806036]
  98. Anal Bioanal Chem. 2003 Jan;375(2):264-9 [PMID: 12560971]
  99. Neurobiol Dis. 2017 Sep;105:109-116 [PMID: 28587921]
  100. Pain. 2022 Feb 1;163(2):e328-e332 [PMID: 33990113]
  101. Neuroscientist. 2012 Oct;18(5):467-86 [PMID: 22547529]
  102. Nature. 1983 Dec 15-21;306(5944):686-8 [PMID: 6656869]
  103. Neurochem Res. 2019 Apr;44(4):763-775 [PMID: 30603983]
  104. Inflamm Res. 1999 Dec;48(12):621-5 [PMID: 10669112]
  105. Life Sci. 2020 Jul 1;252:117642 [PMID: 32259600]
  106. Phytochemistry. 2005 Apr;66(8):935-40 [PMID: 15934134]
  107. Pharmacol Ther. 2020 May;209:107496 [PMID: 32001311]
  108. J Ethnopharmacol. 2010 May 4;129(1):115-20 [PMID: 20307640]
  109. Brain Res Bull. 2008 Sep 5;77(1):27-32 [PMID: 18639742]
  110. Eur J Pharmacol. 2021 Apr 15;897:173945 [PMID: 33596416]
  111. Acta Pharmacol Sin. 2008 Feb;29(2):245-51 [PMID: 18215355]
  112. J Cardiovasc Pharmacol. 1992 Oct;20(4):513-9 [PMID: 1280704]
  113. Drug Discov Today. 2019 Sep;24(9):1710-1714 [PMID: 31158510]
  114. Drug Discov Today. 2015 Jan;20(1):3-6 [PMID: 25218931]
  115. J Pharm Pharmacol. 2020 Jun;72(6):798-806 [PMID: 32056223]
  116. Springerplus. 2016 Jun 30;5(1):938 [PMID: 27386382]
  117. Mol Psychiatry. 2003 Apr;8(4):373-82 [PMID: 12740594]
  118. Mol Med Rep. 2013 Feb;7(2):481-4 [PMID: 23175437]
  119. Front Med. 2014 Sep;8(3):265-7 [PMID: 24584833]
  120. Pharmacol Ther. 2016 Mar;159:1-22 [PMID: 26826604]
  121. Reumatismo. 2012 Sep 28;64(4):268-74 [PMID: 23024971]
  122. Br J Anaesth. 2019 Aug;123(2):e273-e283 [PMID: 31079836]
  123. Nat Prod Commun. 2010 Jun;5(6):877-82 [PMID: 20614814]
  124. Pharmacol Res. 2020 Jan;151:104541 [PMID: 31733326]
  125. Int J Mol Sci. 2019 Jun 26;20(13): [PMID: 31248061]
  126. BMC Infect Dis. 2015 Mar 25;15:153 [PMID: 25887373]
  127. Mol Cell Biochem. 2008 Aug;315(1-2):41-9 [PMID: 18498042]
  128. Nat Rev Neurosci. 2005 Jul;6(7):521-32 [PMID: 15995723]
  129. J Pharm Sci. 1975 Jun;64(6):1040-1 [PMID: 1133725]
  130. Drug Discov Today. 2012 May;17(9-10):425-34 [PMID: 22269134]
  131. Eur J Drug Metab Pharmacokinet. 2011 Jun;36(2):95-101 [PMID: 21424683]
  132. J Neuroinflammation. 2010 Apr 16;7:27 [PMID: 20398373]
  133. Shock. 2009 Sep;32(3):263-9 [PMID: 19106818]
  134. Food Funct. 2021 Apr 7;12(7):2874-2885 [PMID: 33877243]
  135. Scand J Pain. 2017 Dec 29;8(1):28-34 [PMID: 29911609]
  136. Pain. 2007 Oct;131(3):262-271 [PMID: 17317010]
  137. Br J Clin Pharmacol. 2014 Feb;77(2):357-67 [PMID: 23432384]
  138. Phytochemistry. 2016 May;125:5-13 [PMID: 26899361]
  139. Clin Obstet Gynecol. 2019 Mar;62(1):22-36 [PMID: 30383545]
  140. Sci Rep. 2016 Dec 02;6:37850 [PMID: 27910870]
  141. Pain Ther. 2020 Dec;9(2):487-498 [PMID: 33085012]
  142. Curr Neuropharmacol. 2007 Dec;5(4):289-94 [PMID: 19305745]
  143. Int J Cancer. 2017 Aug 15;141(4):805-815 [PMID: 28500623]
  144. Pain. 2002 Oct;99(3):557-566 [PMID: 12406532]
  145. Neurochem Res. 2016 Nov;41(11):3147-3159 [PMID: 27561290]
  146. Trends Pharmacol Sci. 2005 Apr;26(4):178-82 [PMID: 15808341]
  147. Cochrane Database Syst Rev. 2012 Dec 12;12:CD008242 [PMID: 23235657]
  148. Neurol Sci. 2014 Jun;35(6):815-21 [PMID: 24337989]
  149. J Ethnopharmacol. 2003 Oct;88(2-3):205-14 [PMID: 12963144]
  150. Arch Intern Med. 2003 Nov 10;163(20):2433-45 [PMID: 14609780]
  151. Inflamm Res. 2013 May;62(5):527-35 [PMID: 23525659]
  152. Pain Med. 2011 Apr;12(4):657-67 [PMID: 21392250]
  153. Planta Med. 2008 Oct;74(12):1423-9 [PMID: 18683125]
  154. Scand J Pain. 2017 Dec 29;7(1):9-14 [PMID: 29911599]
  155. Biol Pharm Bull. 2018 May 1;41(5):690-696 [PMID: 29467345]
  156. Pain Res Treat. 2012;2012:486590 [PMID: 22191023]
  157. Cell Mol Neurobiol. 2018 Mar;38(2):529-540 [PMID: 28488010]
  158. Oxid Med Cell Longev. 2017;2017:8416763 [PMID: 28819546]
  159. Molecules. 2018 Oct 02;23(10): [PMID: 30279331]
  160. Mediators Inflamm. 2015;2015:752512 [PMID: 26819501]
  161. Libyan J Med. 2020 Dec;15(1):1730550 [PMID: 32066339]
  162. Purinergic Signal. 2017 Jun;13(2):227-235 [PMID: 28054206]
  163. Immunopharmacol Immunotoxicol. 2014 Feb;36(1):43-51 [PMID: 24294901]
  164. Mol Pain. 2018 Jan-Dec;14:1744806918793232 [PMID: 30027795]
  165. J Ethnopharmacol. 2020 Nov 15;262:113164 [PMID: 32738391]
  166. Planta Med. 2003 Jun;69(6):506-12 [PMID: 12865967]
  167. Food Chem Toxicol. 2018 Sep;119:309-325 [PMID: 29486278]
  168. Int Immunopharmacol. 2004 Feb;4(2):235-44 [PMID: 14996415]
  169. Arzneimittelforschung. 1988 Jul;38(7):892-5 [PMID: 3207434]
  170. Int Immunopharmacol. 2007 Jun;7(6):816-23 [PMID: 17466915]
  171. Sci Rep. 2014 Dec 01;4:7270 [PMID: 25434829]
  172. Chin Med. 2019 Aug 02;14:26 [PMID: 31388350]
  173. Front Pharmacol. 2020 Oct 29;11:538137 [PMID: 33536900]
  174. J Ethnopharmacol. 2019 Apr 6;233:56-63 [PMID: 30599222]
  175. J Ethnopharmacol. 2014 Jul 3;154(3):537-63 [PMID: 24768769]
  176. Med J Aust. 2013 Sep 16;199(S6):S17-20 [PMID: 25370278]
  177. Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):591-609 [PMID: 31006834]
  178. Curr Med Sci. 2020 Feb;40(1):130-137 [PMID: 32166675]
  179. Pain. 2013 Dec;154 Suppl 1:S10-S28 [PMID: 23792284]
  180. Glia. 2019 Jun;67(6):1017-1035 [PMID: 30548343]
  181. Neurosci Lett. 2008 Oct 10;443(3):209-12 [PMID: 18692550]
  182. Acta Pharmacol Sin. 2002 Dec;23(12):1107-13 [PMID: 12466048]
  183. J Ethnopharmacol. 2011 Oct 11;137(3):1477-85 [PMID: 21878383]
  184. BMC Cancer. 2018 May 22;18(1):579 [PMID: 29783929]
  185. Pain. 2001 Nov;94(2):215-224 [PMID: 11690735]
  186. Mol Med Rep. 2013 Jun;7(6):1819-25 [PMID: 23563643]
  187. Science. 2016 Nov 4;354(6312):572-577 [PMID: 27811267]
  188. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996 Sep;16(9):525-8 [PMID: 9772598]
  189. J Ethnopharmacol. 2005 Apr 8;98(1-2):37-43 [PMID: 15763362]
  190. PLoS One. 2014 Apr 10;9(4):e94586 [PMID: 24722146]
  191. Acta Pharmacol Sin. 2003 Nov;24(11):1150-4 [PMID: 14627501]
  192. PLoS One. 2012;7(6):e38627 [PMID: 22715398]
  193. Phytomedicine. 2013 Aug 15;20(11):1039-45 [PMID: 23746756]
  194. Int Immunopharmacol. 2018 Feb;55:105-111 [PMID: 29241159]
  195. Pharm Biol. 2013 Jul;51(7):844-50 [PMID: 23627473]
  196. Eur J Pharmacol. 2013 Dec 5;721(1-3):5-11 [PMID: 24120369]
  197. Biomed Res Int. 2017;2017:3754942 [PMID: 28164119]
  198. Nat Rev Drug Discov. 2021 Feb;20(2):85-90 [PMID: 33402709]
  199. Trends Neurosci. 1994 Jan;17(1):22-30 [PMID: 7511846]
  200. Chem Pharm Bull (Tokyo). 1992 Apr;40(4):954-6 [PMID: 1525949]
  201. Curr Top Behav Neurosci. 2020;45:153-166 [PMID: 32468494]
  202. Inflammopharmacology. 2013 Jun;21(3):201-32 [PMID: 23719833]
  203. FEBS Open Bio. 2020 Jan;10(1):118-126 [PMID: 31715069]
  204. J Nat Med. 2016 Apr;70(2):207-16 [PMID: 26711833]
  205. Org Biomol Chem. 2004 Aug 21;2(16):2281-6 [PMID: 15305207]
  206. Psychopharmacology (Berl). 2019 Nov;236(11):3169-3182 [PMID: 31172225]

Word Cloud

Created with Highcharts 10.0.0drugpainchronicalkaloidstherapeuticChineseTCManalgesicincludingdCloudestablishmentdrugseffectsmedicineintroducedderivedconceptanalgesicsefficacy"inhibitiondirectlydiscovery"Jun""Chen""Zuo""Shi"majorChroniconeprevalenthealthproblemscomplexCurrentmedicationmainlydependentanticonvulsantstricyclicantidepressantsopioidergicHoweverlimitedefficacyevenseveresideturnedinterestseparatedtraditionalusuallyactmultipletargetsarticlebest-studiedtetrahydropalmatinealoperineoxysophocarpinematrinesinomenineligustrazineevodiaminebrucinetetrandrineStopholidinelappaconitinefocusingmechanismspotentialclinicalapplicationsbetterdescribemechanismadopteddrug-cloudtheoryillustratedfullspectrummultitargettwodimensions"directionchannelsactivatingγ-AminobutyricAcid/opioidreceptorssuppresssignal"backgroundreducingneuronalinflammation/oxidativestressglialcellactivationrestoringbalanceexcitatoryinhibitoryneurotransmissioncurerootcausesEmpiricalevidenceshowedcombinationbeneficial30-50%patientspromoteeffectivecombinationsancientregimencombinesherbalpropertiesactssymptomdiseasegeneratesbackgroundsalutarysupportivefunctionsfacilitatesdeliverytargetedtissueSubsequentlyusinginterpretedeffectestablishedcompositionscontainingmaycontributealternativemodelAnalgesicAlkaloidsDerivedTraditionalMedicinePainManagementtradcombinationaltherapy

Similar Articles

Cited By